South Korea Biosurgery Market Size, Share, and COVID-19 Impact Analysis, By Application (Orthopedic, Neuro, Spine), By Product (Anti-Adhesive, Synthetic Surgical Sealant, Cell-Based Matrices), and South Korea Biosurgery Market Insights, Industry Trend, Forecasts to 2035.

South Korea Biosurgery Market Insights Forecasts to 2035

• The South Korea Biosurgery Market size is Expected to Grow at a CAGR of around 5.5% from 2025 to 2035
• The South Korea Biosurgery Market size is expected to hold a significant Share by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Biosurgery Market is anticipated to grow at a CAGR of 5.5% from 2025 to 2035. The market is driven by rising consumer demand for plant-based, functional foods and increasing awareness of traditional medicinal ingredients. The popularity of convenient, pre-packaged sliced formats also boosts market growth across households and foodservice sectors.

Market Overview

The South Korea biosurgery market refers to the area of surgical devices and biologic adjuncts that are intended to control bleeding, seal tissue, minimize adhesions, and augment soft-tissue or bone repair during and after surgery. Specifically, this market involves hemostatic agents, surgical sealants and adhesives, adhesion barriers, bone graft substitutes, and soft-tissue attachments utilized across numerous surgical specialties. In South Korea, the market is expected to grow driven by increased surgical volumes, increased use of minimally invasive and reconstructive procedures, and a growing population of elderly patients that have more surgery in orthopaedic and cardiovascular. Also, advanced hospital infrastructure, working local distribution networks from global medtech companies, and a growing preference amongst treating clinicians for the use of biologic and synthetic adjuncts will see in greater adoption.

Report Coverage

This research report categorizes the market for the South Korea biosurgery market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea biosurgery market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea biosurgery market.

Driving Factors

The South Korea biosurgery market is driven by increased surgical volumes, an aging population with greater orthopedic and cardiovascular needs, and increasing adoption of minimally invasive procedures. With the combination of advanced hospital infrastructure, active local distribution of global medtech products, and greater clinician preference to decrease postoperative complications and improve surgical outcomes using biologic hemostats, sealants, and adhesion barriers, the market is expected to expand in the next few years.

Restraining Factors

The South Korea biosurgery market faces restraint through expensive product costs, limited or complicated reimbursement for specialized biosurgical products, and strict regulatory processes. The delay in usage of specialty biologic and synthetic adjuncts in specialized surgery in smaller hospitals is likely due to budget limitations and procurement and purchasing issues.

Market Segmentation

The South Korea biosurgery market share is classified into application and product.

• The orthopedic segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea biosurgery market is segmented by application into orthopedic, neuro, and spine. Among these, the orthopedic segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growth can be attributed to the frequency of degenerative joint disorders, fracture repair, and joint replacements in an ageing population. Segment growth is driven further by the increasingly widespread adoption of biosurgical products in orthopedics, including bone repair, adhesion prevention, and tissue sealing.

• The anti-adhesive segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea biosurgery market is segmented by product into anti-adhesive, synthetic surgical sealant, and cell-based matrices. Among these, the anti-adhesive segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growth of the biosurgical products segment is supported by the increasing use of biosurgical products in both abdominal surgeries, orthopedic surgeries, and spinal surgeries in order to limit or prevent post-surgical adhesions. The use of biosurgical products in surgical procedures improves clinical outcomes for patients, limits the risks of revision surgeries, and reduces healthcare costs. Continued innovation of new products and in support of favorable clinical evidence, biosurgical products have significant potential for better adoption in hospitals and surgical centers.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea biosurgery market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Johnson & Johnson
• Medtronic plc
• Baxter International Inc.
• B. Braun Melsungen AG
• Sanofi S.A.
• Stryker Corporation
• Integra LifeSciences Holdings Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea biosurgery market based on the below-mentioned segments:

South Korea Biosurgery Market, By Application

• Orthopedic
• Neuro
• Spine

South Korea Biosurgery Market, By Product

• Anti-Adhesive
• Synthetic Surgical Sealant
• Cell-Based Matrices